DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer's; on track to generate top-line data H1 2025 - - Recent third-party clinical data esta ...

Legend Biotech Corporation (NASDAQ:LEGN ... most recently at ZielBio and prior to that at Checkmate Pharmaceuticals. Before ...

The company is also raising its full-year guidance to $14.9 billion in adjusted EBITDA, an 8.8% increase from its last ...

Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; ...

Ricci has spent his entire technology career in the pharmaceutical industry, beginning at Bristol-Myers Squibb, then Johnson ...

With a diverse drug portfolio and a robust pipeline of future drugs to market, this big pharma brand will play a major role ...

The combined company would be led by Cullgen Chairman and Chief Executive Ying Luo and Cullgen's board, with the addition of one representative of Pulmatrix. It would operate under the Cullgen name ...

The reacquisition of the full global commercial rights to ociperlimab and TEVIMBRA in the third quarter of 2023 resulted in ...

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo The number of sexually transmitted ...

Liberty Media Corp. Series C Liberty Formula One-0.55% $24.59B Liberty Media Corp. Series A Liberty Formula One-0.44% $24.59B Liberty Broadband Corp. Cl A-1.04% $14.07B Liberty Broadband Corp. Cl ...

With over a decade of groundbreaking innovative solutions in Vietnam's pharmaceutical sector ... in collaboration with Roche, ...